Childhood Vaccines Market Research Report, Share, and Forecast to 2025

Posted by rekha on October 16th, 2019

The global childhood vaccines market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Some of the key factors influencing the market growth include rising demand for vaccinations has increased over the last few years, increasing focus on immunization programs, growing company initiatives to enhance vaccine R&D and growing number of hospitals and healthcare institutions. In 2018, nearby 116.3 million children below the age of 1 year received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine internationally. With growing administration of vaccines, the vaccines business will enlarge considerably over the coming years. However, high cost of developing vaccines and inadequate access to vaccines are the major factors hindering the market growth. In addition, high growth in emerging economies provides huge growth opportunity for the market.

Global childhood vaccines market segmented on the basis of vaccine type, route of administration, application, composition, end-user and region.

For request sample:

Inactivated Vaccines dominate the Global Childhood Vaccines Market

Based on vaccine type, global childhood vaccines market is segmented into inactivated vaccines, attenuated vaccines, toxoid vaccines, subunit vaccines, conjugate vaccines and others. Inactivated Vaccines held considerable market growth during estimated period.Inactivated vaccines use the killed version of the germ that causes a disease. They can be composed of both whole viruses or bacteria, or fractions of either. Inactivated vaccines typically don’t offer immunity that’s as strong as live vaccines. So one may need several doses over time in order to get ongoing immunity against diseases.

North America Leads the Global Childhood Vaccines market


PBI’s global childhood vaccines market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis.North America accounted for larger revenue share in global childhood vaccines market with considerable CAGR. The growth in this region can be attributed to rising funds by government organizations and companies to encourage vaccination as well as advance new vaccines. U.S is the major contributor for the growth of the market in this region. Also, Europe held considerable market share during estimated period owing to increasing the number of pharmaceutical industry players and growing disposable income. India, China and Australia are anticipated to have substantial growth for the market due to the rising vaccination initiatives by governments.


Strategic Collaborations are the Key Strategies Adopted by Market Players


Global childhood vaccines market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, In June 2017, Takeda collaborated with BE to develop low-cost vaccines for low and middle-income countries.

Key player’s profiles in the report are MedImmune (U.S.), Johnson & Johnson Services Inc. (U.S.), Merck & Co.Inc. (U.S.), Sanofi  (France), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (U.S.), Astellas Pharma (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), GlaxoSmithKline plc(U.K.), Protein Sciences Corporation (U.S.), Novartis AG (Switzerland), Organobalance GMBH (Germany), Biological E (India) and Mabvax Therapeutics Holdings Inc. (U.S.).

Precision Business Insights (PBI) in its report titled “Global Childhood Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market.

Detailed Segmentation


By Vaccine Type       

o   Inactivated Vaccines

o   Attenuated Vaccines

o   Toxoid Vaccines

o   Subunit Vaccines

o   Conjugate Vaccines

o   Others

By Route of Administration  

o   Oral

o   Intramuscular

o   Intradermal

o   Subcutaneous

o   Intranasal

By Application           

o   Diphtheria

o   Pertussis

o   Tetanus

o   Polio

o   Measles

o   Hepatitis-B

o   Others

By Composition         

o   Mono vaccines

o   Combination vaccines

By End-User  

o   Hospitals

o   Clinics

o   Vaccination Centres


By Geography

o     North America

  • U.S
  • Canada

o     Europe

  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

o     Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

o     Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

o     Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

For more information:

Like it? Share it!


About the Author

Joined: July 26th, 2019
Articles Posted: 219

More by this author